Associations of Advanced Glycation End Products with Sleep Disorders in Chinese Adults

Linyan Li, Jianhe Guo, Xiaoling Liang, Yue Huang, Qiang Wang, Yuxi Luo, L. King, Liangkai Chen, Xiaolin Peng, Hong Yan, Ruikun He, Jun Wang, Xiaobo Peng, Liegang LiuNutrients 2024 · DOI

TL;DR

This study reveals a significant link between elevated levels of advanced glycation end products (AGEs) in the blood and an increased risk of various sleep disorders, including short sleep duration, poor sleep quality, excessive daytime sleepiness, and insomnia, in Chinese adults. These findings suggest that AGEs, often found in processed foods, could be a dietary factor contributing to sleep disturbances, highlighting the potential for dietary interventions to improve sleep health.

What Problem Does This Paper Address?

Sleep disorders are a growing public health concern, impacting physical and mental well-being and increasing the risk of other serious health conditions. While diet is known to influence sleep, the specific role of advanced glycation end products (AGEs) in sleep health remains unclear. AGEs are compounds formed through the Maillard reaction, often found in processed foods, and are implicated in various diseases due to their pro-oxidant and inflammatory effects. This paper aims to investigate the association between circulating AGEs and different types of sleep disorders in a Chinese adult population, addressing the gap in understanding this potential dietary link to sleep disturbances.

Methods

This cross-sectional study utilized data from the Tongji-Shenzhen Cohort (TJSZC). The researchers measured plasma levels of three specific AGEs: Nɛ-(Carboxymethyl)lysine (CML), Nɛ-(Carboxyethyl)lysine (CEL), and Nδ-(5-hydro-5-methyl-4-imidazolone-2-yl)-ornithine (MG-H1) using ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Sleep disorders were assessed through self-reported questionnaires (sleep duration, Pittsburgh Sleep Quality Index for quality, Epworth Sleepiness Scale for daytime sleepiness, and insomnia symptoms) and objective actigraphy for a subset of participants. Statistical analyses included multivariable logistic regression to assess individual AGE associations, weighted quantile sum (WQS) regression to evaluate the combined effect of AGEs, and Bayesian kernel machine regression (BKMR) to explore non-linear and non-additive relationships.

Datasets

The study used baseline survey data from the Tongji-Shenzhen Cohort (TJSZC), collected between 2019 and 2020. A total of 1732 Chinese adults were included in the final analysis. A subset of 383 participants provided data on subjective sleep quality and daytime sleepiness, and a further subset of 182 participants provided wrist actigraphy data for objective sleep assessment. No new datasets were introduced.

Key Insights and Ideas

  • AGEs as a potential culprit for poor sleep: The study strongly suggests that higher levels of AGEs in the blood are not just correlated with, but likely contribute to, various sleep problems. This moves beyond simply observing an association to proposing a causal link.
  • CML takes center stage: Among the AGEs studied, CML consistently emerged as the most significant contributor to sleep disorders, particularly in the combined exposure models. This points to CML as a key target for further investigation.
  • Dietary patterns matter: The study highlights that insufficient vegetable intake is linked to higher CEL levels, and higher dietary fat intake is also associated with increased CEL. This reinforces the idea that dietary choices directly influence AGE levels and, consequently, sleep health.
  • Beyond subjective reports: The use of actigraphy data, while on a smaller subset, adds a layer of objectivity, confirming that AGEs are associated with objective measures of sleep, not just how people feel about their sleep.

Key Results

  • Each IQR increment in plasma CML was associated with increased odds of:
  • Short sleep duration (OR: 1.11 [1.00, 1.23])
    • Poor sleep quality (OR: 1.33 [1.10, 1.60])
    • Excessive daytime sleepiness (OR: 1.33 [1.11, 1.60])
    • Insomnia (OR: 1.29 [1.05, 1.59])
  • Similar associations were found for CEL and MG-H1, though CML showed the most consistent and strongest links across different sleep disorders.
  • WQS regression indicated that a mixture of AGEs was positively associated with increased risks of poor sleep quality, excessive daytime sleepiness, and insomnia. CML contributed the most weight (e.g., 91.95% for excessive daytime sleepiness) to these combined risks.
  • BKMR analysis further supported the association between AGEs and sleep disorders, with higher AGE mixture concentrations linked to elevated risks.
  • Actigraphy data showed inverse associations between AGEs and total sleep time and sleep efficiency, and positive associations with wake after sleep onset.

Limitations and Future Work

The authors acknowledge several limitations:

  • Cross-sectional design: This prevents the establishment of definitive causal relationships. It's possible that poor sleep could lead to dietary changes that increase AGEs, creating a vicious cycle.
  • Limited dietary data: The study could not calculate specific dietary AGE intake, making it difficult to pinpoint exact food sources and their contributions.
  • Unobserved confounders: The potential influence of factors like sleeping medication use could not be fully accounted for.
  • Focus on specific AGEs: While three key AGEs were studied, there are many others that could also play a role.
  • Mechanistic insights: While associations are strong, the precise biological mechanisms by which AGEs affect sleep are not fully elucidated and warrant further investigation.

Future work should focus on longitudinal studies and randomized controlled trials to confirm causality. Further research into the specific dietary sources of AGEs and their impact on plasma AGE levels and sleep is recommended. Investigating the underlying molecular mechanisms and exploring the role of other AGEs are also important next steps.

Summary updated

Abstract

These findings support a significant association between plasma AGEs and sleep disorders, indicating that AGEs may adversely influence sleep health and reducing the intake of AGEs may facilitate preventing and ameliorating sleep disorders.
BibTeX
@inproceedings{li2024associations,
  author = {Linyan Li and Jianhe Guo and Xiaoling Liang and Yue Huang and Qiang Wang and Yuxi Luo and L. King and Liangkai Chen and Xiaolin Peng and Hong Yan and Ruikun He and Jun Wang and Xiaobo Peng and Liegang Liu},
  title = {{Associations of Advanced Glycation End Products with Sleep Disorders in Chinese Adults}},
  booktitle = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16193282},
}
Figure